Additional Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

    Newport Native MD, Inc.
    Newport Beach CA. 92663
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

    Southeastern Research Center
    Winston-Salem NC. 27103
    View Details

  • Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

    Massachusetts General Hospital
    Boston MA. 02114
    View Details

  • Move With Air: Physiological Response Assessment

    Centre of Innovative Medicine of the McGill University Health Centre
    Montreal QC. H4A 3J1
    View Details

  • Move With Air: Exercise Training Study

    Centre of Innovative Medicine of the McGill University Health Centre
    Montreal QC. H4A 3J1
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Arizona Pulmonary Specialists
    Phoenix AZ. 85012
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Summit Health
    Bend OR. 97701
    View Details

  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Vincent Medical Group
    Indianapolis IN. 46260
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Kansas City KS. 66062
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Charleston SC. 29425
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Rochester MN. 55905
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Birmingham AL. 35209
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Baltimore MD. 21224
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Cleveland OH. 44195
    View Details

  • Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Philadelphia PA. 19140
    View Details

  • Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation

    University of South Florida/ Tampa General Hospital
    Tampa FL. 33606
    View Details

  • Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

    University of Oklahoma Health Sciences Center (OUHSC)
    Oklahoma City OK. 73104-5417
    View Details

  • Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

    Southeastern Research Center
    Winston-Salem NC. 27103-4007
    View Details

  • Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

    Metroplex Pulmonary and Sleep Center
    McKinney TX. 75069-1898
    View Details